http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year
-
Intelligent Bio Solutions adds 33 new customer accounts in Q1
-
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
-
Intelligent Bio Solutions secures UK contract with industrial service provider
-
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
-
Intelligent Bio Solutions delays FDA submission to second half 2026
-
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
-
Intelligent Bio Solutions must resubmit FDA drug screening application
-
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
-
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
-
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
-
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
-
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
-
Intelligent Bio Solutions submits FDA response for drug screening device
-
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch
-
Intelligent Bio Solutions wins London transport drug testing contract
-
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
-
Intelligent Bio Solutions raises $3.8 million through warrant exercise agreement
-
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
-
Intelligent Bio Solutions collects data to strengthen FDA submission
-
Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience
-
Intelligent Bio Solutions signs global distribution deal for SmarTest Patch
-
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
-
Intelligent Bio Solutions adds wearable drug detection patch to portfolio
-
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
-
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
-
Intelligent Bio Solutions (INBS) and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
-
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
-
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
-
Intelligent Bio Solutions (INBS) Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
-
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
-
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
-
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
-
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
-
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements
-
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
-
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
-
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
-
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
-
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
-
Intelligent Bio Solutions (INBS) Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
-
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
-
Intelligent Bio Solutions' (INBS) FDA Clearance Process Remains on Track for 2025 U.S. Launch
-
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
-
Intelligent Bio Solutions (INBS) to Expand U.S. IP Portfolio with Expected Patent Grant
-
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant
-
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th
-
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
-
Intelligent Bio Solutions (INBS) Announces Proposed Public Offering of Common Stock
-
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
